The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia

På svenska

Author

Department/s

Publishing year

2008-06

Language

English

Pages

11-1209

Publication/Series

Leukemia & Lymphoma

Volume

49

Issue

6

Document type

Journal article

Publisher

Taylor & Francis

Topic

  • Cardiac and Cardiovascular Systems
  • Infectious Medicine

Keywords

  • Adult
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols
  • Cyclophosphamide
  • Humans
  • Hypertension, Pulmonary
  • Male
  • Rituximab
  • Vidarabine
  • Waldenstrom Macroglobulinemia

Status

Published

ISBN/ISSN/Other

  • ISSN: 1029-2403